2016, Yellow fever, ICG annual meeting report
Overview
On 13 and 14 September, the International Coordinating Group (ICG) on vaccine provision for Yellow Fever held its annual meeting to review the activities during 2015-2016 and epidemic response and to define the vaccine needs of the 2017 Yellow Fever vaccine stockpile. Discussion also focused on the Yellow Fever ICG mechanism, including the decision making process and criteria for vaccine release; the communication of the requests to countries and partners; the forecasting for 2017; the procurement strategy and processes (modus operandi); and the financing strategy. On the second day with the ICG extended partners the focus of the discussion was to share information with donors and manufacturers on the vaccine demand and projected supply of Yellow fever vaccine.
On 13 and 14 September, the International Coordinating Group (ICG) on vaccine provision for Yellow Fever held its annual meeting to review the activities during 2015-2016 and epidemic response and to define the vaccine needs of the 2017 Yellow Fever vaccine stockpile. Discussion also focused on the Yellow Fever ICG mechanism, including the decision making process and criteria for vaccine release; the communication of the requests to countries and partners; the forecasting for 2017; the procurement strategy and processes (modus operandi); and the financing strategy. On the second day with the ICG extended partners the focus of the discussion was to share information with donors and manufacturers on the vaccine demand and projected supply of Yellow fever vaccine.
